In Alzheimer’s disease, we reported that adeno-associated virus (AAV) over expression of sFKN in the hippocampus of the rTg4510 mouse model of tauopathy resulted in reduced tau pathology, amelioration of neuron loss, and reduction of microgliosis. This evidence concerns the gene MAPT and Alzheimer disease.